139 related articles for article (PubMed ID: 8761273)
1. Duchenne phenotype with in-frame deletion removing major portion of dystrophin rod: threshold effect for deletion size?
Fanin M; Freda MP; Vitiello L; Danieli GA; Pegoraro E; Angelini C
Muscle Nerve; 1996 Sep; 19(9):1154-60. PubMed ID: 8761273
[TBL] [Abstract][Full Text] [Related]
2. Dystrophin expression in Duchenne patients with "in-frame" gene deletions.
Nicholson LV; Bushby KM; Johnson MA; Gardner-Medwin D; Ginjaar IB
Neuropediatrics; 1993 Apr; 24(2):93-7. PubMed ID: 8327067
[TBL] [Abstract][Full Text] [Related]
3. Deletions in the 5' region of dystrophin and resulting phenotypes.
Muntoni F; Gobbi P; Sewry C; Sherratt T; Taylor J; Sandhu SK; Abbs S; Roberts R; Hodgson SV; Bobrow M
J Med Genet; 1994 Nov; 31(11):843-7. PubMed ID: 7853367
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical analysis of dystrophin-associated proteins in Becker/Duchenne muscular dystrophy with huge in-frame deletions in the NH2-terminal and rod domains of dystrophin.
Matsumura K; Burghes AH; Mora M; Tomé FM; Morandi L; Cornello F; Leturcq F; Jeanpierre M; Kaplan JC; Reinert P
J Clin Invest; 1994 Jan; 93(1):99-105. PubMed ID: 8282827
[TBL] [Abstract][Full Text] [Related]
5. Large in-frame deletions of the rod-shaped domain of the dystrophin gene resulting in severe phenotype.
Nevo Y; Muntoni F; Sewry C; Legum C; Kutai M; Harel S; Dubowitz V
Isr Med Assoc J; 2003 Feb; 5(2):94-7. PubMed ID: 12674656
[TBL] [Abstract][Full Text] [Related]
6. A severe muscular dystrophy patient with an internally deleted very short (110 kD) dystrophin: presence of the binding site for dystrophin-associated glycoprotein (DAG) may not be enough for physiological function of dystrophin.
Arikawa-Hirasawa E; Koga R; Tsukahara T; Nonaka I; Mitsudome A; Goto K; Beggs AH; Arahata K
Neuromuscul Disord; 1995 Sep; 5(5):429-38. PubMed ID: 7496177
[TBL] [Abstract][Full Text] [Related]
7. Characterization of translational frame exception patients in Duchenne/Becker muscular dystrophy.
Winnard AV; Klein CJ; Coovert DD; Prior T; Papp A; Snyder P; Bulman DE; Ray PN; McAndrew P; King W
Hum Mol Genet; 1993 Jun; 2(6):737-44. PubMed ID: 8353493
[TBL] [Abstract][Full Text] [Related]
8. The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion.
Koenig M; Beggs AH; Moyer M; Scherpf S; Heindrich K; Bettecken T; Meng G; Müller CR; Lindlöf M; Kaariainen H; de la Chapellet A; Kiuru A; Savontaus ML; Gilgenkrantz H; Récan D; Chelly J; Kaplan JC; Covone AE; Archidiacono N; Romeo G; Liechti-Gailati S; Schneider V; Braga S; Moser H; Darras BT; Murphy P; Francke U; Chen JD; Morgan G; Denton M; Greenberg CR; Wrogemann K; Blonden LA; van Paassen MB; van Ommen GJ; Kunkel LM
Am J Hum Genet; 1989 Oct; 45(4):498-506. PubMed ID: 2491009
[TBL] [Abstract][Full Text] [Related]
9. Deletions in the dystrophin gene: analysis of Duchenne and Becker muscular dystrophy patients in Quebec.
Simard LR; Gingras F; Delvoye N; Vanasse M; Melançon SB; Labuda D
Hum Genet; 1992 Jun; 89(4):419-24. PubMed ID: 1618490
[TBL] [Abstract][Full Text] [Related]
10. Clinical variability in Becker muscular dystrophy. Genetic, biochemical and immunohistochemical correlates.
Comi GP; Prelle A; Bresolin N; Moggio M; Bardoni A; Gallanti A; Vita G; Toscano A; Ferro MT; Bordoni A
Brain; 1994 Feb; 117 ( Pt 1)():1-14. PubMed ID: 8149204
[TBL] [Abstract][Full Text] [Related]
11. [Molecular pathology of Duchenne and Becker muscular dystrophy].
Gilgenkrantz H; Chelly J; Récan D; Chafey P; Kaplan JC
C R Seances Soc Biol Fil; 1992; 186(4):349-53. PubMed ID: 1301222
[TBL] [Abstract][Full Text] [Related]
12. Effect of dystrophin gene deletions on mRNA levels and processing in Duchenne and Becker muscular dystrophies.
Chelly J; Gilgenkrantz H; Lambert M; Hamard G; Chafey P; Récan D; Katz P; de la Chapelle A; Koenig M; Ginjaar IB
Cell; 1990 Dec; 63(6):1239-48. PubMed ID: 2261642
[TBL] [Abstract][Full Text] [Related]
13. Sarcolemmal expression of dystrophin C-terminus but reduced expression of 6q-dystrophin-related protein in two DMD patients with large deletions of the dystrophin gene.
Bittner RE; Shorny S; Ferlings R; Sperl W; Kress W; Müller CR; Cremer M; Léger JJ; Voit T
Neuromuscul Disord; 1995 Mar; 5(2):81-92. PubMed ID: 7767097
[TBL] [Abstract][Full Text] [Related]
14. Dystrophin quantification and clinical correlations in Becker muscular dystrophy: implications for clinical trials.
Anthony K; Cirak S; Torelli S; Tasca G; Feng L; Arechavala-Gomeza V; Armaroli A; Guglieri M; Straathof CS; Verschuuren JJ; Aartsma-Rus A; Helderman-van den Enden P; Bushby K; Straub V; Sewry C; Ferlini A; Ricci E; Morgan JE; Muntoni F
Brain; 2011 Dec; 134(Pt 12):3547-59. PubMed ID: 22102647
[TBL] [Abstract][Full Text] [Related]
15. Dystrophin characterization in BMD patients: correlation of abnormal protein with clinical phenotype.
Morandi L; Mora M; Confalonieri V; Barresi R; Di Blasi C; Brugnoni R; Bernasconi P; Mantegazza R; Dworzak F; Antozzi C
J Neurol Sci; 1995 Oct; 132(2):146-55. PubMed ID: 8543940
[TBL] [Abstract][Full Text] [Related]
16. Amino-terminal deletion of 53% of dystrophin results in an intermediate Duchenne-Becker muscular dystrophy phenotype.
Takeshima Y; Nishio H; Narita N; Wada H; Ishikawa Y; Ishikawa Y; Minami R; Nakamura H; Matsuo M
Neurology; 1994 Sep; 44(9):1648-51. PubMed ID: 7936290
[TBL] [Abstract][Full Text] [Related]
17. Dystrophin in frameshift deletion patients with Becker muscular dystrophy.
Gangopadhyay SB; Sherratt TG; Heckmatt JZ; Dubowitz V; Miller G; Shokeir M; Ray PN; Strong PN; Worton RG
Am J Hum Genet; 1992 Sep; 51(3):562-70. PubMed ID: 1496988
[TBL] [Abstract][Full Text] [Related]
18. Additional dystrophin fragment in Becker muscular dystrophy may result from proteolytic cleavage at deletion junctions.
Beggs AH; Hoffman EP; Kunkel LM
Am J Med Genet; 1992 Oct; 44(3):378-81. PubMed ID: 1488990
[TBL] [Abstract][Full Text] [Related]
19. Becker muscular dystrophy with onset after 60 years.
Heald A; Anderson LV; Bushby KM; Shaw PJ
Neurology; 1994 Dec; 44(12):2388-90. PubMed ID: 7991131
[TBL] [Abstract][Full Text] [Related]
20. Defective dystrophin in Duchenne and Becker dystrophy myotubes in cell culture.
Sklar RM; Beggs AH; Lev AA; Specht L; Shapiro F; Brown RH
Neurology; 1990 Dec; 40(12):1854-8. PubMed ID: 1701042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
